Although some studies have shown a decrease in the frequency of circulating CD4+ T cells due to localization in the lung and other tissues, other studies have reported an increased number of CCR6+ CD4+ T cells in patients with severe COVID-19 (104, 243, 244). This evidence concerns the gene CD4 and COVID-19.